What is PulseOn?
PulseOn is a pioneering company headquartered in Finland, dedicated to the development of advanced arrhythmia detection devices and sophisticated analysis software tailored for professional medical applications. Their proprietary wearable solution employs beat-to-beat accurate optical heart-rate technology, enabling continuous 24/7 monitoring for arrhythmias, with a particular focus on atrial fibrillation, a primary risk factor for strokes. The device is engineered for user convenience, requiring no patient training and allowing for extended wear without impacting daily activities. PulseOn's innovation is geared towards enhancing stroke prevention through timely diagnosis of arrhythmias.
How much funding has PulseOn raised?
PulseOn has raised a total of $2.7M across 2 funding rounds:
Angel/Seed
$1.4M
Unspecified
$1.3M
Angel/Seed (2013): $1.4M, investors not publicly disclosed
Unspecified (2014): $1.3M, investors not publicly disclosed
What's next for PulseOn?
The substantial enterprise-level funding and recent strategic investment signal a pivotal phase for PulseOn. This capital infusion is expected to accelerate the company's product development, expand its market reach, and bolster its research and development initiatives in cardiac monitoring technology. The focus on scaling operations and further refining its analysis software suggests a strategic push towards solidifying its position in the competitive medical device market, potentially leading to broader adoption of its stroke-prevention solutions.
See full PulseOn company page
